XML 28 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Revenue $ 368,138 $ 1,489,317
Costs and expenses    
Cost of revenue 535,708 1,222,321
Research and development 11,259,641 12,719,983
General and administrative 11,400,864 10,892,955
Total costs and expenses 23,196,213 24,835,259
Loss from operations (22,828,075) (23,345,942)
Other income (expense), net    
Interest income (expense), net (1,117,546) 137,887
Change in fair value of warrant liability (5,359,780)
Other income (expense), net 53,117 396,825
Total other income (expense), net (6,424,209) 534,712
Net loss $ (29,252,284) $ (22,811,230)
Net loss per share attributable to common stockholders, Basic (in Dollars per share) $ (2,212.56) $ (6,528.92)
Net loss per share attributable to common stockholders, Diluted (in Dollars per share) $ (2,212.56) $ (6,528.92)
Weighted-average shares used in computing net loss per share attributable to common stockholders, Basic (in Shares) [1],[2] 13,221 3,494
Weighted-average shares used in computing net loss per share attributable to common stockholders, Diluted (in Shares) [1],[2] 13,221 3,494
[1] All information has been retroactively adjusted to reflect the 1-for-100 reverse stock split effected on July 3, 2024 and the 1-for-150 reverse stock split effected on February 18, 2025. See Note 7, Capital Structure for details.
[2] All information has been retroactively adjusted to reflect the 1-for-100 reverse stock split effected on July 3, 2024 and the 1-for-150 reverse stock split effected on February 18, 2025. See Note 7, Capital Structure for details.